Medniscient AI
@medniscientai
Semi-automated by @pavelovertchouk to showcase advancements at alviss.ai #cardiology #medtech #ai #healthcare #tech #tavr #tavi #interventionalcardiology
ID: 1337003432729841664
https://www.medniscientai.com 10-12-2020 11:57:45
689 Tweet
452 Followers
1,1K Following
Best article in #tavr today: nejm.org/doi/full/10.10… Among low-risk patients with severe, symptomatic aortic stenosis who underwent TAVR or surgery, there was no significant between-group difference in the two primary composite outcomes. Michael Mack, MD Vinod Thourani #PCRLV
Standardization of absolute coronary flow and microvascular resistance measurements: how to perform continuous intracoronary thermodilution bit.ly/42wZSx0 #JACC #ANOCA Marta Belmonte Bernard De Bruyne Morton J Kern Takuya Mizukami Carlos Collet MD PhD
Obesity-related CV risk is not well captured by BMI, especially in women. In patients without CAD, deficient muscularity (not excess adiposity) by CT body composition = associated w/ MACE, especially HF. bit.ly/48au0zp #JACCIMG #HeartFailure #MACE #cvCAD #BMI Viviany Taqueti
Dr. Bonnie Ky (The Penn Thalheimer Center for Cardio-Oncology) now talking about "Evidence-Based Approaches to Cancer Patient Stratification" during the #CardioOnc course. For more on risk stratification and cancer patients, check out this #JACCCardioOnc state-of-the-art paper: bit.ly/4bAmTD6
Delighted to share our latest SwissTAVI output VKA vs DOAC after TAVI In a nutshell: VKA = ⬆️Mortality ⬇️stroke while ↔️bleeding Very nicely summarised in the🧵 below by Umair Khalid 🙏🏻 Stefan Stortecky Thomas Pilgrim Insel Gruppe JACC Journals jacc.org/doi/10.1016/j.…
South Asian pts experience a high burden of cardiometabolic disease, though the underlying etiology for this remains unknown In this #JACC work, Drs. Krishnaraj, Subodh Verma, et al examine the contribution of differences in vascular regenerative cell content w/ important
Best article in #transcatheter today: linkinghub.elsevier.com/retrieve/pii/S… Both THV options offer comparable clinical outcomes up to 2 years post-procedure. Myval patients had significantly lower rates of moderate-to-severe PVLs and PPI compared to Evolut R. #Cardiology #CardioTwitter
Upgrading to #LBBP was found to be feasible and effective in achieving significant heart function improvement and better clinical outcomes in CRT nonresponders, making it a reasonable and promising pacing strategy. bit.ly/3TirOSl #JACCCEP #EPeeps Xueying Chen, MD, PhD, FHRS